UCB6114
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCB6114, covering 2025-05-29 to 2025-05-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors [Phase 1, Phase 2]